MCM
NVO

Murphy Capital Management’s Novo Nordisk NVO Stock Holding History

Murphy Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,320
Closed -$270K – 315
2015
Q4 		$270K Buy
+9,320
New +$258K 0.04% 260
2014
Q4 		– Sell
-20,800
Closed -$495K – 349
2014
Q3 		$495K Sell
20,800
-14,600
-41% -$336K 0.08% 209
2014
Q2 		$817K Buy
35,400
+3,300
+10% +$72.9K 0.13% 166
2014
Q1 		$732K Buy
+32,100
New +$684K 0.12% 169

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Murphy Capital Management's NVO Position: Q1 2016 in Review

Murphy Capital Management sold out of Novo Nordisk (NVO) in Q1 2016, closing a stake of 9,320 shares — an estimated $270K sold.

Murphy Capital Management first reported a position in NVO in Q1 2014 and held it in 4 quarters. The position peaked at $817K in Q2 2014. 535 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

  • Murphy Capital Management reported no remaining Novo Nordisk position as of Q1 2016 after selling out during the quarter.
  • Murphy Capital Management sold 9,320 Novo Nordisk shares in Q1 2016, an estimated $270K.
  • Murphy Capital Management first reported a position in Novo Nordisk in Q1 2014 and held it in 4 quarters.
  • Murphy Capital Management's Novo Nordisk position peaked at $817K in Q2 2014.
  • 535 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on Murphy Capital Management's 13F filing for Q1 2016, filed 18 Apr 2016.